Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 2/20 | 0.61 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | CYP11B1 | P15538 | 4/20 | 0.52 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.52 |
| ▸ | MKNK2 | Q9HBH9 | 2/20 | 0.52 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.52 |
| ▸ | PRKACA | P17612 | 1/20 | 0.52 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.52 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.52 |
| ▸ | NTRK3 | Q16288 | 1/20 | 0.52 |
| ▸ | PKN2 | Q16513 | 1/20 | 0.52 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.52 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.52 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.46 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanide SCHEMBL28250393 | 0.92 | CYP1A1 (0.54) | CYP1A1CYP1B1ALDH1A1CYP11B1CYP11B2 | |
| SCHEMBL5702666 | 0.86 | CYP1A1 (0.74) | CYP1A1CYP1B1CYP11B1CYP11B2MKNK2 | |
| SCHEMBL1863295 | 0.85 | CYP1A1 (0.48) | CYP1A1CYP1B1ALDH1A1CYP11B1CYP11B2 | |
| SCHEMBL18893667 | 0.85 | CYP1A1 (0.48) | CYP1A1CYP1B1ALDH1A1CYP11B1CYP11B2 | |
| SCHEMBL29465753 | 0.84 | — | — | |
| SCHEMBL91463 | 0.84 | — | — | |
| SCHEMBL10781062 | 0.83 | CYP11B1 (0.58) | CYP1A1CYP1B1ALDH1A1CYP11B1CYP11B2 | |
| SCHEMBL12925127 | 0.83 | CYP1A1 (0.47) | CYP1A1CYP1B1ALDH1A1CYP11B1CYP11B2 | |
| SCHEMBL14805696 | 0.83 | CYP1A1 (0.47) | CYP1A1CYP1B1ALDH1A1CYP11B1CYP11B2 | |
| SCHEMBL11999815 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119569648-A | Novel energetic compound and preparation method thereof | 信阳师范学院 | 2025-03-07 | — | — | CN | claimed |
| CN-115960411-A | Wire irradiation material and preparation method thereof | 江苏火凤凰线缆系统技术股份有限公司 | 2023-04-14 | — | — | CN | claimed |
| CN-109293538-B | Preparation method of aryl sulfone compound, catalyst used for extraction and extraction method of aryl sulfone compound | 温州大学 | 2020-12-08 | — | — | CN | claimed |
| CN-109836446-A | A kind of pyridine alkynes precursor and its synthetic method | 重庆大学 | 2019-06-04 | — | — | CN | claimed |
| CN-109293538-A | A kind of preparation method of aromatic sulphones compounds and the extracting method for extracting used catalyst and aromatic sulphones compounds | 温州大学 | 2019-02-01 | — | — | CN | claimed |
| CN-108291306-A | Plating bath composition and method for electroless plating of palladium | 埃托特克德国有限公司 | 2018-07-17 | — | — | CN | claimed |
| EP-4737514-A1 | RUBBER COMPOSITION AND TIRE | Sumitomo Rubber Industries, Ltd. (JP) | 2026-05-06 | — | — | EP | disclosed |
| US-20250214977-A1 | STAT6 INHIBITORS AND USES THEREOF | KYMERA THERAPEUTICS, INC. | 2025-07-03 | — | — | US | disclosed |
| CN-119569648-A | Novel energetic compound and preparation method thereof | 信阳师范学院 | 2025-03-07 | — | — | CN | disclosed |
| WO-2023220741-A1 | ALPHA 4 BETA 7 INTEGRIN MODULATORS AND USES THEREOF | DICE MOLECULES SV, INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| CN-116891468-A | Thiazole compound and application thereof | 南京再明医药有限公司 | 2023-10-17 | — | — | CN | disclosed |
| US-20230234925-A1 | GPR52 MODULATORS AND METHODS OF USE | NEUROCRINE BIOSCIENCES, INC. | 2023-07-27 | — | — | US | disclosed |
| US-20230203214-A1 | AZACOUMARIN AND AZATHIOCOUMARIN DERIVATIVES FOR USE IN OPTICALLY ACTIVE DEVICES | AMO Ireland (IE) | 2023-06-29 | — | — | US | disclosed |
| CN-1077792-C | Pyridyl bisphosphonates for use as therapeutic agents | LEIRAS OY (FI) | 2002-01-16 | — | — | CN | disclosed |
| EP-1120409-A1 | 2,3-DISUBSTITUTED PYRIDINE DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF, DRUG COMPOSITIONS CONTAINING THE SAME AND INTERMEDIATES FOR THE PREPARATION | Dainippon Pharmaceutical Co., Ltd. (JP) | 2001-08-01 | — | — | EP | disclosed |
| CN-1149830-A | Pyridylbisphosphonates for use as therapeutical agent | LEIRAS OY (FI) | 1997-05-14 | — | — | CN | disclosed |
| EP-0746336-A1 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN, INC. (US) | 1996-12-11 | — | — | EP | disclosed |
| EP-0746336-A4 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN INC (US) | 1996-07-26 | — | — | EP | disclosed |
| WO-1993002703-A1 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
| US-4713080-A | OXIDATIVE COLORING | WELLA AKTIENGESELLSCHAFT (DE) | 1987-12-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234925-A1 | GPR52 MODULATORS AND METHODS OF USE | GPR52, GPR68, GPR35 | CYP1A1 2102/4885CYP1B1 2384/4885ALDH1A1 1831/4885 |
| US-20250214977-A1 | STAT6 INHIBITORS AND USES THEREOF | STAT6, STAT5B, STAT5A | CYP1A1 4562/4885CYP1B1 3897/4885ALDH1A1 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.